New Treatment Option for advanced HER2-positive Breast Cancer

被引：0
|
作者：
Forstmeyer, D. [1 ]
机构：
[1] Univ Klinikum Leipzig, Univ Krebszentrum Leipzig UCCL, D-04103 Leipzig, Germany
来源：
ONKOLOGE | 2013年 / 19卷 / 01期
关键词：
D O I：
10.1007/s00761-012-2375-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [21] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Jelovac, Danijela
    Wolff, Antonio C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 230 - 239
  • [22] Treatment strategy for HER2-positive breast cancer
    Hirofumi Mukai
    International Journal of Clinical Oncology, 2010, 15 : 335 - 340
  • [23] INDIVIDUALIZED TREATMENT FOR HER2-POSITIVE BREAST CANCER
    Takano, Toshimi
    ANNALS OF ONCOLOGY, 2014, 25
  • [24] Systemic Therapies for HER2-Positive Advanced Breast Cancer
    Angelis, Vasileios
    Okines, Alicia F. C.
    CANCERS, 2024, 16 (01)
  • [25] Two Drugs for Advanced HER2-Positive Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1611): : 182 - 184
  • [26] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
  • [27] New Option for HER2-positive Breast Cancer. First Trastuzumab Biosimilar available
    Eiden, Petra
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (7-8) : 485 - 485
  • [28] Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer
    Duco, Marissa R.
    Murdock, Joshua L.
    Reeves, David J.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (03) : 254 - 261
  • [29] New Option for HER2-positive Breast Cancer First Trastuzumab-Biosimilar available
    Eiden, Petra
    BREAST CARE, 2018, 13 (03) : 221 - 221
  • [30] Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective
    Ferrario, Cristiano
    Christofides, Anna
    Joy, Anil Abraham
    Laing, Kara
    Gelmon, Karen
    Brezden-Masley, Christine
    CURRENT ONCOLOGY, 2022, 29 (04) : 2720 - 2734
12345